[HTML][HTML] MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - Journal of biomedical science, 2013 - Springer
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
[PDF][PDF] MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - 2013 - cyberleninka.org
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
[PDF][PDF] MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - 2013 - core.ac.uk
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
[HTML][HTML] MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - Journal of Biomedical Science, 2013 - ncbi.nlm.nih.gov
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - Journal of biomedical science, 2013 - pubmed.ncbi.nlm.nih.gov
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
[HTML][HTML] MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - Journal of Biomedical Science, 2013 - jbiomedsci.biomedcentral.com
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - Journal of Biomedical Science, 2013 - search.proquest.com
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
[PDF][PDF] MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - 2013 - scienceopen.com
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
[PDF][PDF] MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - 2013 - academia.edu
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy
KKW To - Journal of Biomedical Science, 2013 - go.gale.com
Multidrug resistance (MDR) is a major obstacle to successful cancer treatment. It is often
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …
associated with an increased efflux of a variety of structurally unrelated anticancer drugs by …